HOME >> MEDICINE >> NEWS
Partnership between NIAID and Sequella yields promising new TB drug for clinical testing

The need for new drugs against tuberculosis (TB) has never been more urgent, as the global burden of the disease continues to grow, and the incidence of extensive drug-resistant (XDR) TB, a virtually untreatable disease, continues to rise. A key component in advancing new health care interventions for TB is the creation of productive partnerships between pharmaceutical companies and the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health.

The success of one such public-private partnership has been demonstrated by Sequella, Inc., which recently received clearance from the Food and Drug Administration to enter Phase I clinical trials with their TB drug candidate SQ109.

SQ109 was discovered in NIAID's intramural laboratories in 1999, and developed with extensive support from NIAID as well as the National Cancer Institute/NIAID Inter-Institute Program for the Development of AIDS-related Therapeutics. (For the history of SQ109 development with NIAID funding, see "Kitchen Sink" at www.niaid.nih.gov/news/focuson/tb/research/treating/default.htm).

These efforts are part of a wide array of NIAID-supported TB research projects, from fundamental research to understand Mycobacterium tuberculosis, the organism that causes TB, through product-oriented translational and clinical studies of potential methods of TB prevention and treatment. The successful transition of SQ109 from the laboratory to clinical testing not only represents a major milestone for the NIAID TB program and Sequella, but also speaks to the successes public-private partnerships can yield.


'"/>

Contact: NIAID News Office
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
12-Sep-2006


Page: 1

Related medicine news :

1. Health Partnership Act endorsed By American College of Physicians
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Explaining a link between strokes and Alzheimers
4. Researchers call for investigation into links between khat use and psychiatric disorders
5. Comparison of patients access to new and better cancer drugs reveals inequalities between countries
6. No link found between autism and celiac disease
7. Research demonstrates link between domestic violence and asthma
8. Correlation between bile duct obstruction and ductal cancer found
9. Health gap between social groups widens in later life
10. Molecular differences between early and advanced melanomas could provide new drug targets
11. Queens studies find new links between wine, fermented foods and cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... ... August 31, 2018 , ... Nitro Circus hosted the inaugural A Night to ... action sports gathering to celebrate the life of Erik Roner, world-renowned skier, skydiver and ... wife, Annika and their two small children, Oskar (8) and Kasper (4). A portion ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... South Jersey Gastroenterology for another year. Dr. Savon has been active in gastrointestinal ... leaders in comprehensive care for all gastrointestinal diseases and disorders for the past ...
(Date:8/31/2018)... ... August 31, 2018 , ... ZPower, the ... of Nitin Arneja to Chief Information Officer. Arneja previously served as Director of ... technology solutions that protect, optimize, scale, and innovate the business. , Prior ...
(Date:8/29/2018)... ... , ... Shady Grove Fertility (SGF), with now five locations and ... two of their offices this September. Their Harrisburg, PA office is relocating ... on the campus of UPMC PinnacleHealth Fredericksen Outpatient Center. , The practices Reading, ...
(Date:8/29/2018)... ... August 29, 2018 , ... Autism is ... communicate with others. Physically, it is not possible to identify people that suffer ... be challenged. People with autism may need assistance in developing skills, or to ...
Breaking Medicine News(10 mins):
(Date:9/12/2018)... ... September 13, 2018 , ... Safety Reporting in Global ... — 1:30 p.m. – 3:00 p.m. ET, http://info.fdanews.com/safety-reporting-in-global-clinical-trials , Clinical research ... as fifty percent. , This can be due to a lack of ...
(Date:9/7/2018)... ... September 06, 2018 , ... This year, the California Society of Plastic ... presentation of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at the 68th CSPS Annual ... the upcoming ASPS (American Society of Plastic Surgeons) meeting in Chicago this fall. , ...
(Date:9/7/2018)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has written a new post this ... , Yisrayl scolds mainstream religions for allowing and even promoting the use of pagan titles ... in the Name, and to take that away, shows there is an intentional attempt to ...
Breaking Medicine Technology:
Cached News: